Skip to content

Clinical Study on the Treatment of Simple Obesity Due to Spleen Deficiency and Dampness Obstruction with Qihuang Acupuncture Therapy

Clinical Study on the Treatment of Simple Obesity Due to Spleen Deficiency and Dampness Obstruction with Qihuang Acupuncture Therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001227
Enrollment
Unknown
Registered
2025-06-19
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Simple obesity

Interventions

Qihuang acupuncture therapy group, sham acupuncture group:Lifestyle interventions (including balanced diet and regular exercise)
Sham acupuncture group:Fake acupuncture

Sponsors

Guangzhou University of Chinese Medicine First Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Meet the criteria of BMI = 28.0 kg/m²; accompanied by symptoms such as fatigue, heavy limbs, edema, poor appetite, and loose stools; (2) Have not used other weight loss therapies or oral weight loss medications in the past three months; (3) Age between 18 and 55 years old, with no gender restrictions; (4) Voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Patients who: (1) do not meet the criteria for simple obesity; (2) have obesity caused by hypothalamic, pituitary disorders, hypothyroidism, or other diseases or drug-related reasons; (3) are allergic to the treatment devices and materials used in this study, infected patients, those prone to bleeding, patients with scars, or allergic constitutions; (4) suffer from severe organic diseases of the heart, brain, kidneys, hematological disorders, or severe psychiatric diseases; (5) are in the pre-pregnancy, pregnancy, or lactation period; (6) have dermatitis or serious skin conditions at the selected acupuncture points; (7) have taken weight-loss related medications or are currently undergoing weight loss within the last three months; (8) according to the researcher's judgment, have other reasons that make them unsuitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
Body Mass Index;Waist-to-hip ratio measurement;body weight;waist circumference;

Secondary

MeasureTime frame
Interleukin 6;Acetylcholine receptor antibody test;Insulin antibody test;serum adrenocorticotropic hormone;Plasma cortisol;Progastrin-releasing peptide;

Countries

China

Contacts

Public ContactHuang Zipei

Guangzhou University of Chinese Medicine First Affiliated Hospital

506890522@qq.com15918703389

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026